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A B S T R A C T The phenomenon of redistribution of surface membrane immunoglobulin (Ig) components (capping) has been well described in mouse lymphoid cells. The characteristics of this process in human lymphocytes are less clear. This study characterizes the phenomenon of surface membrane Ig redistribution of normal and chronic lymphocytic leukemia (CLL) lymphocytes with the use of fluoroscein-labeled anti-Ig sera. Normal lymphocytes underwent rapid cap formation after incubation with anti-Ig serum in the cold and subsequent rewarming. The morphology was characteristic with aggregation over the pole of the cell opposite the nucleus and over the uropod when present. The process was energy dependent but independent of protein synthesis, and could be inhibited by vincristine, vinblastine, and colchicine but not by cytochalasin B. CLL cells, on the other hand, though showing fluorescent complex aggregation on the surface, rarely demonstrated unidirectional movement of these aggregates to form a cap. Cap formation in these cells could not be stimulated by supplementing the energy source or protein concentration of the medium nor by adding glutamic acid which could partially reverse the vincristine and vinblastine inhibition of normal capping. The failure of agents which inhibit motility to inhibit capping of the normal lymphocytes suggests that active locomotion is not a direct prerequisite for capping. The results also suggest the involvement of microtubules in normal capping and the possibility that abnormal membrane structure or microtubular function could explain the failure of CLL cells to behave normally in this regard. The role of this cellular defect in the immune deficiencies exhibited by many patients with CLL, however, is not established.
A preliminary report has appeared as an abstract in: 1973. Clin. Res. 21 as a component of the surface membrane and has been defined as the "B cell" or bone marrow-derived population mainly through studies of mouse lymphocytes (1, 2) . Studies of human cells utilizing other surface markers as indicators and patients with immunodeficiency diseases (3) confirm this population among normal human peripheral blood lymphocytes and have demonstrated that they generally constitute somewhat less than 25% of normal circulating lymphocytes (4, 2) . Further investigation of the Ig's in the surface membrane has resulted in the description of the "capping phenomenon" (5) (6) (7) . This phenomenon involves the temperature-dependent redistribution of these surface moieties induced by an anti-Ig, Ig reaction at the surface and generally monitored by fluorescent antibody or radioactively labeled antibody techniques. The phenomenon has been well characterized in mouse lymphocytes and shown to be both energy and temperature dependent (5, (8) (9) (10) . These observations have been consistent with the formulation of the "fluid mosaic" concept of surface membrane structure which may apply to many normal cell types and surface markers (11, 12) . This hypothesis suggests that protein moieties of the cell membrane float freely within the lipid components of the membrane and are free to move randomly in lateral motion about the cell surface. Capping has also been observed in a variety of cell types and may be a general property of animal cells (13 (14) . However, studies of human lymphocytes with respect to surface Ig redistribution have been limited and contradictory (15) (16) (17) .
Recent studies in this and other laboratories have indicated that in patients with chronic lymphocytic leukemia (CLL) the peripheral blood lymphocytes are comprised predominantly of cells containing surface membrane Ig (18) (19) (20) (21) . This observation has prompted some to consider the CLL lymphocyte a B cell derivative (22 To determine the redistribution of surface Ig, cells were incubated with FITC-labeled antisera, washed as described above, and removed directly from ice to a microscope slide. The percentage of surface Ig-containing cells exhibiting a unipolar distribution of fluorescence was then determined. Only cells having less than one-third of the surface containing uniformly aggregated immunoglobulin were counted as "capped." Cells containing up to 75%o of the surface labeled with fluorescent anti-Ig antisera were considered intermediate forms while those having total surface labeling were considered diffuse or spotted fluorescent forms. Cells were then incubated at 37°C in M199-G and removed at specified time intervals to determine the percentage of surface Ig-containing cells exhibiting unipolar distribution in a cap arrangement as described above.
Incubation modifications. Attempts to modify the distribution of the surface Ig on normal and chronic lymphocytic leukemia cells were performed by preincubating cells in M199-G containing the appropriate agent for 10 min and performing the entire antiserum incubation and warming procedure in the presence of the agent to be tested. In each instance, except that of cytochalasin B (Imperial Research Laboratory, Cheshire, England), the agent was dissolved directly in M199-G at the desired concentration and this medium was used for subsequent incubations and washes. In this manner the effects of vincristine sulfate and vinblastine sulfate (Eli Lilly and Co., Indianapolis, Human Lymphocyte Capping: Anomalous Behavior of CLL Lymphocytes 85 Ind.), colchicine (Sigma Chemical Co., St. Louis, Mo.), puromycin (Sigma Chemical Co.), and sodium azide (Fisher Scientific Co., Springfield, N. J.), were tested.
Cytochalasin B was first dissolved in 23% ethanol (EtOH) at a concentration of 190 ,ug/ml. Dilutions of 1: 4, 1: 5, 1: 10, and 1: 20 were made with M199-G to give final cytochalasin B concentrations of 48 jtg/ml, 38 j&g/ml, 19 ,gg/ml, and 9.5 Ag/ml in the resultant EtOH dilution. The EtOH concentration was a maximum of 5.7% EtOH/ M199-G. Incubations were performed as described above.
86
H. J. Cohen RESULTS A total of 23 patients with CLL and 20 normal controls were studied. The latter included a spectrum of ages although they were not specifically age matched. As previously reported (18) normal individuals always had less than 30% surface Ig-containing lymphocytes. On the other hand, cells from CLL patients demonstrated a wider spectrum from a small number of patients containing under 10% labeled cells to others with 90% surface Ig-containing cells; the mean was 75% (18) . Studies of the quantitative aspects of surface Ig, complement, and sheep red blood cell receptors in CLL will be reported elsewhere. 2 Membrane immunoglobulin distribution. When viewed immediately at 0C, 95% of the fluorescent lymphocytes among both the CLL and normal individuals had a diffuse or finely spotted ring surface pattern ( Fig. 1 a and d of a given CLL lymphocyte was considerably less than that of a normal Ig-containing cell (Fig. 1 e) . Upon warming the incubation mixture to 37°C a characteristic sequence of changes was observed in the progression of cells from the ring to the cap form. This differed considerably between normal and CLL lymphocytes. Initially most fluorescent lymphocytes of both groups exhibited diffuse or finely spotted ring fluorescence ( Fig. 1 a and of clear area on the surface (Fig. 1 e) . At 15 min the majority of fluorescent normal cells demonstrated clearing of two-thirds of the cell surface with fluorescence remaining at one pole of the cell often tightly aggregated at this pole (Fig. lb) . At this time 80% of the CLL cells remained in a spotted fluorescent distribution but the aggregates appeared somewhat larger than before and fewer in number. At 30 min the CLL pattern remained the same but more than 75 % of the normal cells were in a capped configuration with many of them occupying even less surface area than before ( Fig. 1 c and f) . When normal cells were in the capped configuration the fluorescence formed a homogenous border of the part of the cell occupied ( Fig. 1  b and c) .
Normal cells were frequently observed to have an elongated bulging process at one end of the cell with a constriction delineating it from the rest of the cell. This elongation, characteristically occurring in lymphocytes at the posterior pole of a moving cell, opposite from the nucleus as in the cells described herein, is called a uropod (24) . Capping was often seen in such cells and when it occurred was always over the uropod end of the cell. Such polarity was observed both in cells floating freely in the medium and those adhering to the surface of the slide (Fig. 1 c) Fig. 2 .
Determination of the proportion of cells in the capped configuration demonstrated the difference between CLL and normal cells within 2 min (Fig. 3) . At this time an average of 38% of normal surface Ig-containing lymphocytes were in the capped configuration (onethird or less of the surface area demonstrating fluorescence in a homogenous area) while only 6% of the CLL cells appeared in this way. The difference was further accentuated at 15 and 30 min when the normals reached 67 and 80%, respectively, while the CLL lymphocytes reached a maximum of 12%. The individual patients with CLL are depicted in Fig. 4 At the next concentration, 48 Ag/ml, the cytochalasin B proved to be quite toxic and caused greater than 60% cell death by trypan blue exclusion thus making any evaluation of capping unreliable. EtOH in M199-G at concentrations up to 5.7%, the highest present in the cytochalasin B preparations, had no effect and was nontoxic. In all other experiments cell viability, as determined by trypan blue exclusion, was always greater than 90% at the completion of the experiment. In all instances involving inhibition of capping, aggregation of the fluorescent complexes was observed but the fluorescence remained in small aggregates distributed about the surface more or less uniformly. Since the effect of vinblastine on mitotic activity has been reported to be counteracted to some extent by glutamate (25) , incubations were performed with vincristine and vinblastine in the presence of sodium glutamate. At concentrations of 10' and 10i M no effect was seen. However, as shown in Table II , at a concentration of 102 M, glutamate could counteract the inhibitory effects of vincristine and vinblastine on the capping phenomenon. This concentration is considerably greater than that present in M199-G (less than 10' M) and is compatible with the marked concentration excess required for the in vivo effect previously reported (25) . On the other hand, glutamate had no effect upon the capping inhibition caused by KCN and sodium azide. In order to determine whether the lack of capping by CLL cells could be the result of a nutritional re-'Jarvis, S. C., H. J. Cohen, and R. Snyderman. 8 7
These experiments were performed as described in legend to Table I except that a series of media were prepared simultaneously containing 10-2 M sodium i-glutamate in addition to the indicated concentration of inhibitor.
quirement not provided by our media, a number of supplements were employed and the results are shown in Table III . As can be seen, neither the addition of serum proteins or extra energy source had any stimulatory effect, nor did they have any inhibitory effect upon capping of normal cells. Moreover, sodium glutamate produced no augmentation in the percentage of CLL cells capping (Table III) . DISCUSSION The capping phenomenon, or redistribution of surface membrane antigens, has been well described using mouse lymphocytes (5-7). It is felt, however, to be a more universal property of cellular membranes since it has been demonstrated in fibroblasts, polymorphonuclear leukocytes, and tumor cells (6, 10, 26) . The redistribution in mouse lymphocytes as previously de- Individual supplements were adjusted to concentrations indicated in M199-G as described in Methods. Cells (2 X 106) in each tube were washed with the indicated medium at 0C then incubated with FITC-anti-Ig serum in the same medium at 0C for 45 min as in Methods. The tubes were then incubated at 370C for 15 min and the cells observed as described scribed (5-7), may be mediated by divalent antibody or antigen binding to the appropriate receptor (5, 16, 27) and appears to occur in two stages. The first stage, which is temperature and energy independent, involves the rapid formation of small aggregates uniformly distributed over the surface of the cell. The next phase, which requires energy and an elevation of temperature to 20'-370C, involves the directional movement of the cross-linked and aggregated receptors to one pole of the cell. Studies of normal human lymphocyte capping have been limited and contradictory. Preud'Homme, Neauport-Sautes, Piat, Silvestre, and Kourilsky (16) reported that both IgM and HL-A surface components would independently redistribute after reacting with a specific fluoroscein-labeled antiserum to form typical caps. Knapp, Bolhuis, Radl, and Hymans (17) also qualitatively demonstrated independent redistribution of IgD and IgM on human lymphocyte surfaces. On the other hand, Ault, Karnovsky, and Unanue (15) studying the lymphocytes from normal subjects failed to demonstrate the capping phenomenon and suggested that human and mouse lymphocytes differ in this regard. The present study, however, clearly demonstrates that normal human peripheral blood lymphocytes exhibit the capping phenomenon, as previously described for mouse cells, and that it follows similar kinetics. Although the relative protein concentration of the medium has been reported to influence Ig redistribution (5, 9) , the divergent findings cannot be explained in this way since the addition of FCS or other protein sources to M199-G was without effect. On the other hand, differences in the antiserum: surface Ig ratio have also been reported to influence capping (5, 9) and the variant results may relate to the specific properties or concentrations of the FITC antisera employed in the study, e.g. antibodies to more Ig determinants, or other less obvious culture conditions. However, our demonstration of the polarity of many of the normal cells with cap formation over the uropod appears to clearly establish the existence of this phenomenon in normal human lymphocytes.
Our inhibitor studies confirm that the second phase of the capping process of human lymphocytes, as previously demonstrated in the mouse lymphocyte system (5) , is dependent upon energy metabolism but not upon protein synthesis. Previous studies of the effects of colchicine and cytochalasin B upon capping have been contradictory and inconclusive but have involved only mouse cells. Colchicine, vincristine, and vinblastine have been reported to dissolve and inhibit the action of microtubules (28) (29) while cytochalasin B appears to affect microfilaments and inhibit cell locomotion (30) . In some reports the colchicine derivatives 90 H. J. Cohen have shown no effect on mouse lymphocyte capping (5, 8, 25) , but one recent study has shown almost complete inhibition of mouse fibroblast capping by colcemid (26) . Ault, Karnovsky, and Unanue (15) found no effect of colchicine on human lymphocyte capping but failed to demonstrate capping initially. Cytochalasin B has been reported to inhibit capping partially at a high concentration (5) but not to do so at lower concentrations associated with less cell death (8, 25, 31) . Vincristine and vinblastine have not been studied. In this study we have demonstrated, for the first time, a clear-cut inhibitory effect of all three microtubularinhibiting agents on the capping phenomenon in human lymphocytes as well as glutamic acid reversal of the action of vincristine and vinblastine. Cytochalasin B,
in concentrations up to toxic levels, failed to inhibit this process. This suggests that microtubules, not microfilaments, are involved in the directional redistribution of the surface aggregates in normal human lymphocyte membranes and is consistent with data from other laboratories which indicates that colcemid tends to "depolarize" cells and allow continuous random membrane movement (32) . It may be postulated that the directional movement of the aggregated receptors requires fixation to an internal stabilizing structure such as microtubules, which pull these aggregates towards one pole of the cell while displacing the nonbound aggregates to the opposite pole. Both microtubules and actin-like microfilaments have been described in submembrane area of lymphocytes (33) although the latter have been more prominent. In addition, a "colchicine-binding" protein has been described which appears to have considerable importance in maintaining topographic stability of the plasma membrane receptors in mouse lymphocytes, and may play a role in directional receptor movement (34) .
Since receptor redistribution appears to occur most often in motile cells and often over the uropod, some have suggested that cell motility might be involved in this process (25, 35 (34) that is crucial to intramembranous Ig redistribution and lacking in CLL lymphocytes. Further information in this regard must await more detailed high resolution morphologic studies of CLL and normal lymphocytes.
Surface markers, especially surface membrane Ig, have been extensively employed as indicators of specific lymphocyte populations, and a number of lymphoproliferative disorders have been designated B-or T-cell derived (22) . However, some studies of malignant lymphoid cells have shown discordance between markers presumably identifying the same population, thus casting some doubt upon the determination of the origin of such cells (18, 41) . Our demonstration of qualitative abnormalities involving Ig components of the CLL lymphocyte membrane should reinforce the danger of considering such abnormal lymphocytes as derived from a specific normal subpopulation of cells solely because of the presence of such surface markers. The role of surface membrane Ig redistribution in the initiation of the immune response is unsettled. Although formation of anti-Ig, Ig complexes on mouse lymphocytes failed to produce stimulation or activation in one report (42) , such an effect of receptor-antigen interactions has not been ruled out, and one may speculate that some of the immune deficiencies exhibited by patients with CLL might be related in part to the abnormality in directional redistribution of Ig receptors.
